{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:21:31Z","timestamp":1760188891328},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1007\/s11926-001-0047-9","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T05:03:24Z","timestamp":1181365404000},"page":"24-28","source":"Crossref","is-referenced-by-count":25,"title":["Phosphocitrate as a potential therapeutic strategy for crystal deposition disease"],"prefix":"10.1007","volume":"3","author":[{"given":"Herman S.","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"47_CR1","first-page":"239","volume":"139","author":"JE Howard","year":"1976","unstructured":"Howard JE: Studies on urinary stone formation: a saga of clinical investigation. Johns Hopkins Med J 1976, 139:239\u2013252.","journal-title":"Johns Hopkins Med J"},{"key":"47_CR2","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1021\/bi00550a039","volume":"19","author":"WP Tew","year":"1980","unstructured":"Tew WP, Mahle CD, Benavides J, et al.: Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxylapatite crystal growth. Biochemistry 1980, 19:1983\u20131988. A paper reporting the synthesis and characterization of phosphocitrate for the first time.","journal-title":"Biochemistry"},{"key":"47_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0006-291X(90)91350-2","volume":"171","author":"HS Cheung","year":"1990","unstructured":"Cheung HS, Sallis JD, Mitchell PG, Struve JA: Inhibition of basic calcium phosphate crystal-induced mitogenesis by phosphocitrate. Biochem Biophys Res Commun 1990, 171:20\u201325.","journal-title":"Biochem Biophys Res Commun"},{"key":"47_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0925-4439(95)00106-9","volume":"1315","author":"HS Cheung","year":"1996","unstructured":"Cheung HS, Sallis JD, Struve JA: Specific inhibition of basic calcium phosphate and calcium pyrophosphate crystalinduction of metalloproteinase synthesis by phosphocitrate. Biochim Biophys Acta 1996, 1315:105\u2013111.","journal-title":"Biochim Biophys Acta"},{"key":"47_CR5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1097-4652(199908)180:2<215::AID-JCP9>3.0.CO;2-J","volume":"180","author":"M Brogley","year":"1999","unstructured":"Brogley M, Cruz M, Cheung HS: Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42\/44 mitogen-activated protein kinase signal transduction pathway. J Cell Physiol 1999, 180:215\u2013224. A study providing evidence that phosphocitrate blocks the crystalinduced metalloproteinase 1 and 3 synthesis via inhibition of p42\/p44 MAPK pathway.","journal-title":"J Cell Physiol"},{"key":"47_CR6","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/art.1780361116","volume":"36","author":"HE Krug","year":"1993","unstructured":"Krug HE, Mahowald ML, Halverson PB, et al.: Phosphocitrate prevents disease progression in murine progressive ankylosis. Arthritis Rheum 1993, 36:1603\u20131611. A paper showing that phosphocitrate can prevent disease progression in a murine model of crystal deposition disease.","journal-title":"Arthritis Rheum"},{"key":"47_CR7","doi-asserted-by":"crossref","first-page":"28082","DOI":"10.1074\/jbc.271.45.28082","volume":"271","author":"HS Cheung","year":"1996","unstructured":"Cheung HS, Kurup IV, Sallis JD, Ryan LM: Inhibition of calcium pyrophosphate dihydrate crystal formation in articular cartilage vesicles and cartilage by phosphocitrate. J Biol Chem 1996, 271:28082\u201328085. A study demonstrating for the first time that phosphocitrate can inhibit the formation of CPPD and HA crystals in articular cartilage vesicle and cartilage explants.","journal-title":"J Biol Chem"},{"key":"47_CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/joca.1998.0227","volume":"7","author":"HS Cheung","year":"1999","unstructured":"Cheung HS, Ryan LM: Phosphocitrate blocks nitric oxideinduced calcification of cartilage and chondrocyte-derived apoptotic bodies. Osteoarthritis Cartilage 1999, 7:409\u2013412.","journal-title":"Osteoarthritis Cartilage"},{"key":"47_CR9","first-page":"257","volume-title":"Rheumatic Disease of America","author":"LM Ryan","year":"1999","unstructured":"Ryan LM, Cheung HS: Role of crystals in osteoarthritis. In Rheumatic Disease of America. Edited by Brandt KD. Philadelphia: W.B. Saunders Co., 1999:257\u2013267."},{"key":"47_CR10","first-page":"134","volume":"49","author":"HS Cheung","year":"1989","unstructured":"Cheung HS, Mitchell PG, Pledger WJ: Induction of expression of c-fos and c-myc protooncogenes by basic calcium phosphate crystal: effect of beta-interferon. Cancer Res 1989, 49:134\u2013138.","journal-title":"Cancer Res"},{"key":"47_CR11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF00571332","volume":"52","author":"GM McCarthy","year":"1993","unstructured":"McCarthy GM, Mitchell PG, Cheung HS: Misoprostol, a prostaglandin E1 analogue, inhibits basic calcium phosphate crystal-induced mitogenesis and collagenase accumulation in human fibroblasts. Calcif Tissue Int 1993, 52:434\u2013437.","journal-title":"Calcif Tissue Int"},{"key":"47_CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0925-4439(94)90064-7","volume":"1226","author":"GM McCarthy","year":"1994","unstructured":"McCarthy GM, Cheung HS: The role of cyclic-3\u2032,\u2032-adenosine monophosphate in prostaglandin-mediated inhibition of basic calcium phosphate crystal-induced mitogenesis and collagenase induction in cultured human fibroblasts. Biochim Biophys Acta 1994, 1226:97\u2013104.","journal-title":"Biochim Biophys Acta"},{"key":"47_CR13","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1073\/pnas.78.9.5528","volume":"78","author":"WP Tew","year":"1981","unstructured":"Tew WP, Malis CD, Howard JE, Lehninger AL: Phosphocitrate inhibits mitochondrial and cytosolic accumulation of calcium in kidney cells in vivo. Proc Natl Acad Sci U S A 1981, 78:5528\u20135532.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"47_CR14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/978-1-4684-7272-1_195","volume-title":"Urolithiasis and Related Clinical Research","author":"MR Brown","year":"1985","unstructured":"Brown MR, Sallis JD: In Urolithiasis and Related Clinical Research. Edited by Schwille PO, Smith LH, Robertson WG, Vahlensieck W. New York: Plenum Press, 1985:891\u2013894."},{"key":"47_CR15","first-page":"191","volume":"50","author":"R Shankar","year":"1985","unstructured":"Shankar R, Crowden S, Sallis JD: Phosphocitrate and its analogueN-sulpho-2-aino tricarballylate inhibit aortic calcification. Atherosclerosis 1985, 50:191\u2013198.","journal-title":"Atherosclerosis"},{"key":"47_CR16","doi-asserted-by":"crossref","first-page":"18920","DOI":"10.1074\/jbc.272.30.18920","volume":"272","author":"D Nair","year":"1997","unstructured":"Nair D, Misra RP, Sallis JD, Cheung HS: Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway. J Biol Chem 1997, 272:18920\u201318925.","journal-title":"J Biol Chem"},{"key":"47_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.1780350218","volume":"35","author":"BA Derfus","year":"1992","unstructured":"Derfus BA, Rachow JW, Mandel NS, et al.: Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro. Arthritis Rheum 1992, 35:231\u2013240.","journal-title":"Arthritis Rheum"},{"key":"47_CR18","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/art.1780351216","volume":"35","author":"LM Ryan","year":"1992","unstructured":"Ryan LM, Kurup IV, Derfus BA, Kushnaryov VM: ATP-induced chondrocalcinosis. Arthritis Rheum 1992, 35:1520\u20131525.","journal-title":"Arthritis Rheum"},{"key":"47_CR19","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1073\/pnas.95.6.3094","volume":"95","author":"S Hashimoto","year":"1998","unstructured":"Hashimoto S, Ochs RL, Rosen F, et al.: Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci USA 1998, 95:3094\u20133099.","journal-title":"Proc Natl Acad Sci USA"},{"key":"47_CR20","first-page":"2103","volume-title":"Arthritis and Allied Conditions","author":"LM Ryan","year":"1996","unstructured":"Ryan LM, McCarty DJ: Calcim pyrophosphate dihydrate crystal deposition disease, pseudogout, and articular chonodrocalcinosis. In Arthritis and Allied Conditions edn 13. Edited by Koopman WJ. Baltimore: Williams and Wilkins; 1996:2103\u20132125.","edition":"edn 13"},{"key":"47_CR21","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/art.1780271212","volume":"27","author":"FT Hakim","year":"1984","unstructured":"Hakim FT, Cranley R, Brown KS, et al.: Hereditary joint disorder in progressive ankylosis (ank\/ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy. Arthritis Rheum 1984, 27:1411\u20131420.","journal-title":"Arthritis Rheum"},{"key":"47_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/10426509308032413","volume":"76","author":"JD Sallis","year":"1993","unstructured":"Sallis JD, Meehan JD, Kamperman H, Anderson ME: Chemically modified phosphocitrate and entrapment in microparticles for sustained inhibition of biomineralization. Phosphorous, Sulfur and Silicon 1993, 76:281\u2013284.","journal-title":"Phosphorous, Sulfur and Silicon"},{"key":"47_CR23","first-page":"27","volume-title":"Methods in Enzymology","author":"E Tomlinson","year":"1985","unstructured":"Tomlinson E, Burger JJ: In Methods in Enzymology. Edited by Widder KJ, Tomlinson E. New York: Academic Press, 1985:27\u201343."},{"key":"47_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/path.1711280203","volume":"128","author":"DV Doyle","year":"1979","unstructured":"Doyle DV, Dunn CJ, Willoughby DA: Potassium permanganate induced calcergy: a model to study the effects of drugs on hydroxyapatite crystal deposition. J Pathol 1979, 128:63\u201369.","journal-title":"J Pathol"},{"key":"47_CR25","first-page":"1907","volume":"22","author":"T Shinozaki","year":"1995","unstructured":"Shinozaki T, Pritzker KPH: Polyamines enhance calcium pyrophosphate dihydrate crystal dissolution. J Rheumatol 1995, 22:1907\u20131912.","journal-title":"J Rheumatol"},{"key":"47_CR26","volume-title":"Calcium pyrophosphate crystal forms and the influence of phosphocitrate. Advances in Crystal Growth Inhibitory Technologies","author":"JD Sallis","year":"2001","unstructured":"Sallis JD, Wierzbicki A, Cheung HS: Calcium pyrophosphate crystal forms and the influence of phosphocitrate. Advances in Crystal Growth Inhibitory Technologies. Edited by Amzad A. Philadelphia: Plenum Press, 2001."},{"key":"47_CR27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0166-1280(98)00298-X","volume":"454","author":"A Wierzbicki","year":"1998","unstructured":"WierzbickiA, Cheung HS: Molecular modeling of inhibition of crystals of CPPD by phosphocitrate. J Mol Struct Theochem 1998, 454:287\u2013291. Using newly developed molecular model technology, this study provides evidence for the first time to show how PC inhibits the CPPD crystal formation.","journal-title":"J Mol Struct Theochem"},{"key":"47_CR28","unstructured":"Wierzbicki|A, Cheung HS: Molecular modeling of inhibition of hydroxyapatite crystal by phosphocitrate. J Mol Struct Theochem. 2001. Using similar modeling technology, this paper demonstrates how phosphocitrate can inhibit hydroxyapatite formation."},{"key":"47_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00318050","volume":"56","author":"A Wierzbicki","year":"1995","unstructured":"Wierzbicki A, Sikes CS, Sallis JD, et al.: Scanning electron microscopy and molecular modeling of inhibition of calcium oxalate monohydrate crystal growth by citrate and phosphocitrate. Calcif Tissue Int 1995, 56:297\u2013304.","journal-title":"Calcif Tissue Int"},{"key":"47_CR30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s002239900326","volume":"61","author":"A Wierzbicki","year":"1997","unstructured":"Wierzbicki A, Sallis JD, Stevens ED, et al.: Crystal growth and molecular modeling studies of inhibition of struvite by phosphocitrate. Calcif Tissue Int 1997, 61:216\u2013222.","journal-title":"Calcif Tissue Int"},{"key":"47_CR31","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1074\/jbc.270.8.4108","volume":"270","author":"RS Kaplan","year":"1995","unstructured":"Kaplan RS, Mayor JA, Gremse DA, Wood DO: High level expression and characterization of the mitochondrial citrate transport protein from the yeast Saccharmocyes cerevisiae. J Biol Chem 1995, 270:4108\u20134114.","journal-title":"J Biol Chem"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-001-0047-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-001-0047-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-001-0047-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:47:07Z","timestamp":1559436427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-001-0047-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1007\/s11926-001-0047-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}